pirtobrutinib 100 MG Oral Tablet [Jaypirca]

Managing this medication for someone you care for? Eleplan keeps diagnoses, medications and appointments in one plan.

Start free with Eleplan

Clinical drug

pirtobrutinib 100 MG Oral Tablet [Jaypirca]

100 MG · Oral Tablet · oral

A form of pirtobrutinib →

pirtobrutinib 100 MG Oral Tablet [Jaypirca] — Bruton's tyrosine kinase (BTK) inhibitors. Strength, form, class, interactions & more.

pirtobrutinib 100 MG Oral Tablet [Jaypirca]

Active ingredient

pirtobrutinib →

Classification

Bruton's tyrosine kinase (BTK) inhibitorsKinase Inhibitor

Drug interactions

Pirtobrutinib has several interactions with CYP3A inhibitors and inducers, as well as with sensitive substrates of CYP2C8, CYP2C19, CYP3A, P-gp, and BCRP.

  • majorstrong CYP3A inhibitors — increased risk of adverse reactions
  • majorstrong or moderate CYP3A inducers — reduced efficacy of pirtobrutinib
  • moderatesensitive CYP2C8, CYP2C19, CYP3A, P-gp, or BCRP substrates — increased risk of adverse reactions related to these substrates

Source: RxNorm + openFDA + RxClass + FAERS · 2026

Look up another medication

Powered by Eleplan

A drug lookup is just the start. Eleplan keeps the whole care plan in one place.

Medications, diagnoses, documents, appointments, and the whole care team — organized and always in sync, with Ellie, your AI care assistant, on top of it. Free to start.

Get started freeSee how Eleplan works →